A recent report showed that HNSCC samples with pathogenetic mutations of the tumor suppressors TP53 and/or CDKN2A had a higher mean TMB compared to samples with wildtype genes [103]. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.